Abcam enters cell editing market through acquisition of EdiGene
China-based EdiGene has developed the industry’s largest off-the-shelf diploid library of over 2,800 single clonal knockout (KO) cell lines targeting over 2,600 genes
Breaking News
Low doses of radiation promote cancer-capable cells
A new study has shown that low doses of radiation weigh the odds in favour of cancer-capable mutant cells in the ...
Vitamin K2 technology wins award for NattoPharma spin-off
Kaydence Pharma has received a start-up award at the BIO International convention
British cell and gene therapy accelerator releases annual report
The CGT Catapult has worked on more than 110 projects addressing industry challenges
US Patent and Trademark office declares new CRISPR interference
The new motion follows on from a long history of confusion over the intellectual property of CRISPR/Cas9 technology in ...
UK government releases £125 million in grant funding to support innovators
The cash injection will see businesses turn ideas into new products and services on the market
Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
The German drug-maker plans to combine assets from its cancer immunology portfolio with AMAL’s immunisation platform
Integrated tools for upstream process intensification: Part I
Changes to bioprocessing methodologies are driven by the need for increased speed, a lower cost of goods and greater ...
Teva completes facilities purchase in Pennsylvania
Investment will see the Israeli drug-maker set up a Research & Development campus in the US
Onyx Scientific eyes UK facility expansion for commercial API licence
Licence approval from the MHRA is expected this year and will see the British CRO take customers’ projects from ...
How humanised machine learning is giving the life sciences industry a shot in the arm
The life sciences industry currently finds itself facing a perfect storm of challenges — from society’s rising ...
Recombinant cultures for superior enzyme output
A non-GMP enzyme manufacturing process at Porton Biopharma has been converted from native production to recombinant ...
Small molecule CDMOs reacting to changing market demands
The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...
Pfizer invests $6.3m in paediatric manufacturing in the UK
Kent County Council will match this investment at the Discovery Park site to make more palatable flexible doses for ...
Cobra Biologics and Symbiosis complete $6m collaboration
Partnership found synergies to improve the complexity, time and risk of drug substance and drug product viral vector ...
In Brief
Most Popular in Research
- Vitamin K2 technology wins award for NattoPharma spin-off
- Merck introduces integrated plug-and-play upstream development service
- Parenteral preparations: formulation challenges
- Particle size reduction strategies to improve drug performance
- British cell and gene therapy accelerator releases annual report
Suppliers in research
Reports
